Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.

doi:10.1183/09031936.00078812

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.

The European respiratory journal - 1 Sept 2013

Wheelock Craig E, Goss Victoria M, Balgoma David, Nicholas Ben, Brandsma Joost, Skipp Paul J, Snowden Stuart, Burg Dominic, D'Amico Arnaldo, Horvath Ildiko, Chaiboonchoe Amphun, Ahmed Hassan, Ballereau Stéphane, Rossios Christos, Chung Kian Fan, Montuschi Paolo, Fowler Stephen J, Adcock Ian M, Postle Anthony D, Dahlén Sven-Erik, Rowe Anthony, Sterk Peter J, Auffray Charles, Djukanovic Ratko

Abstract excerpt

Inflammatory lung diseases are highly complex in respect of pathogenesis and relationships between inflammation, clinical disease and response to treatment. Sophisticated large-scale analytical methods to quantify gene expression (transcriptomics), proteins (proteomics), lipids (lipidomics) and metabolites (metabolomics) in the lungs, blood and urine are now available to identify biomarkers that define disease in...

Topics

Biomarkers
Breath Tests
Bronchoalveolar Lavage Fluid
Chromatography, Liquid
Gene Expression Profiling
Humans
Inflammation
Lipid Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Lung Diseases

Mass Spectrometry

Metabolomics

Phenotype

Pneumonia

Proteomics

Sputum

Source

Open in PubMed

Identifiers

PMID: 23397306
DOI: 10.1183/09031936.00078812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.PMID 23397306Read ↗

Using omics approaches to understand pulmonary diseasesSemantic proximity Read ↗

Multi-omics to study chronic respiratory diseases and viral infections.Semantic proximity Read ↗

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and PerspectivesSemantic proximity Read ↗

Toward composite molecular signatures in the phenotyping of asthma.Semantic proximity Read ↗

Biomarkers for precision medicine in airways disease.Semantic proximity Read ↗

Multi-Omics Profiling Approach to Asthma: An Evolving ParadigmSemantic proximity Read ↗

Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary diseaseSemantic proximity Read ↗

Metabolomics in COPD.Semantic proximity Read ↗

Lung microbial-host interface through the lens of multi-omicsSemantic proximity Read ↗

Omics approaches in asthma research: Challenges and opportunitiesSemantic proximity Read ↗

Towards precision medicine: The application of omics technologies in asthma managementSemantic proximity Read ↗

Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.